The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.
In a statement Bharat Biotech clarified that the vaccine's efficacy can only be determined 14 days after the second dose.
Kejriwal will also interact with Prime Minister Narendra Modi, along with his counterparts including West Bengal, Delhi, Maharashtra and Karnataka, where the coronavirus cases are on a much higher side, on June 17.
'I have to treat patients and there they don't like Indians.' 'The patients don't like me, they are not going to come to me, then what is the point of studying there?'
The fact sheet also asked people to inform the vaccinator or a supervising official about their medical condition before taking the vaccine.
The active cases further declined to 11,21,671 comprising 3.83 per cent of the total infections.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances